Advisory Services Network, LLC
Position in EWTX — Edgewise Therapeutics, Inc.
CIK 1573876
Atlanta, GA
Position in EWTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$496,051
+$491,295 QoQ
Shares Held
12,209
+7985.4% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#137
of 223 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EWTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Advisory Services Network, LLC holds $28,927,722 across 25 Biotechnology names. EWTX ranks #19 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
51,566 | $5,845,518 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,289 | $2,674,357 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,141 | $2,553,682 | |
| 4 | OCUL |
Ocular Therapeutix, Inc
|
230,454 | $2,263,058 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,356 | $1,913,344 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
17,371 | $1,415,907 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,135 | $1,409,315 | |
| 8 | EXEL |
Exelixis, Inc.
|
20,558 | $1,118,559 |
All Filings in EWTX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $496,051 | 12,209 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $4,756 | 151 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $2,449 | 151 | Shares | Sole | 2025-11-18 | |
| No filing history on record for this holder in this stock. | ||||||